CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45

L. H. Dang, F. Chen, S. A. Knock, E. H. Huang, J. Feng, H. D. Appelman, D. T. Dang

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


CDX2 is a Drosophila caudal-related homeobox transcription factor that is expressed specifically in the intestine. In mice, ectopic expression of CDX2 in the gastric mucosa gives rise to intestinal metaplasia and in one model, gastric carcinoma. In humans, increased CDX2 expression is associated with gastric intestinal metaplasia and tubular adenocarcinomas. These patterns of expression have shown that CDX2 is important for the initiation of intestinal metaplasia in the gastric mucosa, but the role of CDX2 in established gastric cancer remains unclear. We sought to determine whether CDX2 contributes to tumorigenic potential in established gastric cancer. The CDX2 gene in MKN45 gastric carcinoma cells was disrupted using targeted homologous recombination. The resulting CDX2-/- cells are essentially identical to their parental cells, with the exception of CDX2 ablation. We found no significant differences in the proliferation of CDX2-/- cells compared to CDX2+/+ cells, in vitro or in vivo. Molecular analyses show that loss of CDX2 predominantly altered the expression of genes involved in intestinal glandular differentiation and adhesion. However, there were no microscopic differences in tumor differentiation. We conclude that disruption of CDX2 in MKN45 cells does not significantly affect their tumorigenic potential.

Original languageEnglish (US)
Pages (from-to)2048-2059
Number of pages12
Issue number14
StatePublished - Mar 30 2006
Externally publishedYes


  • CDX2
  • Gastric cancer
  • MKN45
  • Tumorigenicity

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45'. Together they form a unique fingerprint.

Cite this